THROMBOPROPHYLAXIS
Clinical trials for THROMBOPROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new THROMBOPROPHYLAXIS trials appear
Sign up with your email to follow new studies for THROMBOPROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer patients may get clot protection from common blood thinner
Disease control Not yet recruitingThis study tests whether a daily blood thinner pill called apixaban can reduce the risk of blood clots in people with lung cancer who are receiving chemotherapy or similar treatments. About 1,456 participants will take either apixaban or a placebo for six months alongside their c…
Matched conditions: THROMBOPROPHYLAXIS
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
ICU kidney patients may need different blood clot doses, new study hints
Knowledge-focused Not yet recruitingThis study looks at how a blood thinner called enoxaparin works in critically ill patients with kidney failure, some of whom are on a blood-filtering machine. Researchers will measure drug levels in 60 ICU adults to see if standard doses are enough. The goal is to find the right …
Matched conditions: THROMBOPROPHYLAXIS
Phase: NA • Sponsor: Clinique Saint Pierre Ottignies • Aim: Knowledge-focused
Last updated May 17, 2026 05:34 UTC